Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,747 total articles
Ducommun (DCO) combines improving margin mechanics and solid top-line growth with a conservative balance sheet. The stock has pulled back from its August high and looks tradeable on a mid-term horizon: fundamentals support upside while technicals and sector multiple pressure cap near-term gains. This idea outlines an entry, stop, and target with ca…
Omnicom (OMC) trades well below its 52-week high after a pullback, but its free cash flow ($2.389B), dividend yield (~4%), and attractive EV/EBITDA (~7.9) argue for a tactical long. This trade targets a rebound toward the mid-$80s over the next 45 trading days while protecting downside with a clear stop.
Silicon Motion (SIMO) is a fabless NAND flash controller specialist that has surged this year on accelerating NAND demand for AI, broad OEM traction, and product transitions to PCIe Gen5. At a $9.11B market cap and a P/E near 31.7, the stock still offers asymmetric upside vs. downside if you size the trade and use the stop below. I lay out an actio…
Federal Realty (FRT) is a high-quality retail and mixed-use REIT trading near oversold levels with a ~4% yield, strong occupancy, and valuation supported by stable FCF. In a K-shaped recovery where affluent consumers keep spending at premium centers, FRT's selective portfolio and redevelopment activity offer both income and upside. Trade idea: buy …
Illumina is trading up after the market reacted to recent regulatory and industry cues around sequencing-driven oncology diagnostics. Fundamentals remain solid (market cap ~$36.4B, FCF $931M, ROE ~29%), technicals show bullish momentum, and near-term catalysts could re-rate the stock. I recommend a swing trade entry with disciplined risk controls.
Wolfspeed offers asymmetric upside from silicon carbide adoption across EVs, fast charging and data centers while carrying execution and margin risk after recent earnings misses. A disciplined long with a defined entry, stop and $40 target captures a rebound if Gen-5 production and defense partnerships gain traction, while factory assets and post-r…
Sandisk's explosive NAND-driven gains have sharpened the market's focus on AI storage demand. Western Digital sits squarely in that story with strong free cash flow, shrinking net debt, and meaningful revenue lift from cloud and AI customers. This trade idea takes a long position in WDC to capture continued demand and pricing leverage while keeping…
Bob's Discount Furniture is showing playbook-level execution: steady unit economics, expansion that preserves margins, and customer retention that outperforms peers. For traders who want direct exposure, we lay out an actionable long trade with specific entry, target and stop, and a 180-trading-day horizon tied to clear operational catalysts.
Nebius' announcement of meaningful price increases for on-demand GPU and CPU access combined with a 454% YoY Q2 revenue surge and management's $3.2B full-year revenue guide changes the risk/reward. I upgrade the rating and recommend a mid-term long trade with a clear entry at $234.064, stop at $200.00 and target at $300.00. This is a high-risk, hig…
Alphabet (GOOG) offers a compelling long-term trade: market-leading AI exposure, cloud momentum via multi-billion compute deals, and strong cash generation. The stock trades at $351.55 with a market cap of roughly $4.32 trillion, a P/E of ~17.3 and free cash flow north of $53B—fundamentals that support a disciplined long entry toward $400 over the …
South32's plan to divest non-core assets and refocus capital on higher-return mining operations is a catalyst for a valuation re-rating. We initiate a long idea: buy S32 with an entry at $6.50, target $8.75 and a stop at $5.25. The thesis rests on proceeds funding higher-margin projects and a cleaner growth runway; risks include commodity cyclicali…
Ultralife (ULBI) trades near $5.62 with very low cash on the balance sheet but a healthy current ratio, manageable debt, and a record backlog of $115.1M. The trade here is a tactical long: the company looks capable of funding near-term obligations while operational fixes and backlog conversion can drive revenue and margins. Entry $5.60, stop $4.90,…
Post Holdings is trading near its 52-week low after guidance and category weakness spooked the market. The decline in FY2027 earnings looks amplified by mix shifts and one-time items; the company's $553M free cash flow run-rate, $1.48B adjusted EBITDA outlook and $500M Foodservice EBITDA run-rate give room to stabilize leverage and deliver upside. …
Nvidia remains the center of the AI boom and trades at a premium, but its cash generation, recent product cycle upside and moderating valuation metrics argue for a tactical long. This trade lays out a precise entry, stop and target with a 180-trading-day horizon while acknowledging sizable macro and execution risks.
Costco enters earnings with a strong top-line backdrop and a market that cares about one thing now: distribution and margin direction. At roughly $895, valuation is rich on a trailing P/E near 45, but balance-sheet strength, a 26% ROE, and recurring membership cash flows make this a tactical buy into the catalyst on 09/24/2026. Trade plan: enter $8…
First Majestic (AG) sits on roughly $1.03 billion of cash against a $9.47 billion market cap and a diversified North American asset base. That treasury creates optionality: tuck-ins, bolt-ons or even a transformational consolidation could rerate the stock if management deploys capital accretively. This trade idea proposes a long position at $19.20 …
Post Holdings is trading near its 52-week low on weak cereal volumes and transition noise, yet it generates meaningful free cash flow, trades at single-digit EV/EBITDA and low P/E, and is positioning Foodservice and premium cereal to offset retail pressure. This trade idea lays out a mid-term, data-driven long with a clear entry, stop and upside ta…
Arcturus Therapeutics is a high-risk, high-reward biotech idea. The market currently prices ARCT at about $15.51, giving the company a market cap near $440M and an enterprise value near $264M. With a late-stage mRNA rare-disease program (LUNAR-OTC), a relatively clean balance sheet versus enterprise value, and renewed investor interest in mRNA/LNP …
Calumet (CLMT) is positioned to benefit from favorable macro oil dynamics, structural growth in specialty hydrocarbons and a government-backed push into sustainable aviation fuel (SAF). Balance-sheet moves and falling short interest have already tightened the risk premium; this trade targets a move toward $75 over the next 180 trading days while pr…
IPG Photonics is executing a higher-margin pivot toward medical and advanced solutions. The binding offer for Lumibird Medical and strong recent medical growth argue for meaningful upside to earnings and EV/EBITDA multiple expansion — provided execution and end-market cycles hold. Enter near current levels, target $120 over a 180-trading-day horizo…
SanDisk is trading well below its 52-week high but above the levels that reflected last year's reset. Strong free cash flow, double-digit margins and outsized returns on capital combined with accelerating AI and edge storage demand argue that upside still remains. This trade targets a disciplined pullback entry into a stock that can re-rate as grow…
Intel's rebound in 2026 is backed by a clear revenue recovery and a meaningful optionality tied to memory-cycle exposure. The stock is a buy at $123.38 for a long-term trade that leans on potential upside from SK hynix-related developments and an improving AI-driven demand backdrop — but investors must respect execution risk in Intel Foundry Servic…
Mueller Water Products (MWA) is a cash-generative leader in water transmission, distribution and measurement equipment. At a market cap near $3.43B, a P/E around 15.5 and EV/EBITDA of ~9.4, the stock looks reasonably valued. Short-term technical weakness has pushed the RSI into the mid-20s and created a tactical entry for a mid-term rebound driven …
BioMarin (BMRN) combines a growing blockbuster franchise, newly minted royalty income, and a deep rare-disease pipeline. At a $12.4B market cap and current price near $64, the risk/reward favors a long position into 2027. This trade plan targets regulatory and commercial catalysts, with durable cash generation from Voyzogo and a monetized competiti…
B2Gold (BTG) is a large, low-cost gold producer whose shares trade at an attractive price, but operations have been bumpy in 2026. Rising all-in sustaining costs, site incidents and a temporary production hit at Goose raise the risk profile. Still, near-term catalysts — incoming cash from the Agnico sale, Fekola Regional and Goose ramp-ups and stea…
